This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Emory University, Children's Healthcare of Atlanta, Inc., Imperial Innovations Limited. Active years: 2014-2018.
Company Filing History:
8 out of 1,022 
3 out of 86 
1 out of 167 Years Active: 2014-2018
Title: Aiming Sun: Innovator in Quinazoline Derivatives
Introduction
Aiming Sun is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of medicinal chemistry. He holds a total of 8 patents, showcasing his innovative approach to developing therapeutic compounds.
Latest Patents
Among his latest patents, Aiming Sun has developed quinazoline derivatives, compositions, and methods related to these compounds. One notable patent focuses on inhibitors of NADPH-oxidases (Nox enzymes) and/or myeloperoxidase. Another important invention involves quinazoline compounds that act as inhibitors of the histone lysine methyltransferase (HKMTase) EZH2, which are particularly useful in treating diseases where EZH2 inhibition provides therapeutic benefits.
Career Highlights
Aiming Sun has worked with esteemed institutions such as Emory University and Children's Healthcare of Atlanta, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative medical therapies.
Collaborations
Throughout his career, Aiming Sun has collaborated with notable professionals, including James P. Snyder and Richard K. Plemper. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Aiming Sun's work in the field of quinazoline derivatives exemplifies his dedication to advancing medical science through innovation. His patents and collaborations highlight his significant role in developing new therapeutic options.